Does Statin Therapy Reduce the Risks of Mortality and Major Adverse Cardiac and Cerebrovascular Events in Young Adults with End-Stage Renal Disease? Population-Based Cohort Study

Among hemodialysis patients aged more than 40 years old, previous large-scale studies showed statin treatment had no effect on reducing cardiovascular adverse events. However, young-adult-onset end-stage renal disease (ESRD) patients have different physicosocial factors compared to older ESRD patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Ya-Lien, Yang, Huang-Yu, Wu, Chao-Yi, Tsai, Chung-Ying, Chen, Chao-Yu, Hsiao, Ching-Chung, Hsu, Hsiang-Hao, Tian, Ya-Chung, Yen, Chieh-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152985/
https://www.ncbi.nlm.nih.gov/pubmed/34068144
http://dx.doi.org/10.3390/jcm10102097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152985/
https://www.ncbi.nlm.nih.gov/pubmed/34068144
http://dx.doi.org/10.3390/jcm10102097

Ejemplares similares